Abstract
Umbilical cord blood (UCB) cells could be a useful adjunct intervention for infants with HIE. We report our clinical experience of UCB stem cell transplantation in infants with HIE. We selected patients for UCB stem cell transplantation based on following criteria; (1) moderate or severe HIE according to the classification of Sarnat II or III and Thompson score ≥10 points, (2) gestational age ≥36 weeks, (3) body weight at birth >1800 g, (4) born by cesarean section under general anesthesia, and (5) inborn baby. Cases in which collected UCB volume is below 40 mL were excluded from this trial. Brain hypothermia therapy (BHT) was performed simultaneously under supportive mechanical ventilation with sedative agents (fentanyl citrate and midazolam). After collected UCB, CD34-positive cells were separated by SEPAX-2™ (Biosafe SA, Eysins/Nyon, Switzerland) and were transfused to the babies once a day for 12 h to 3 days.
This treatment was successful and safe in all three cases with no adverse effects. A randomized phase II study to provide further safety, feasibility, and efficacy information among a wider number of sites is warranted.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gluckman PD, Wyatt JS, Azzopardi D, Ballard D, Edwards AD, Ferriero DM. Selective head cooling with mild systemic hypothermia to improve neurodevelopmental outcome following neonatal encephalopathy. Lancet. 2005;365:663–70.
Shankaran S, Laptook AR, Ehrenkranz RA, Tyson JE, McDonald SA, Donovan EF, et al. Whole body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med. 2005;35:1574–84.
Azzopardi DV, Strohm B, Edwards AD, Dyet L, Halliday HL, Juszczak E, et al. Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med. 2009;361:1349–58.
Jacobs SE, Morley CJ, Inder TE, Stewart MJ, Smith KR, McNamara PJ, et al. Whole-Body Hypothermia for Term and Near-Term Newborns With Hypoxic-Ischemic Encephalopathy: A Randomized Controlled Trial. Arch Pediatr Adolesc Med. 2011;165:692–700.
Gunn AJ, Gunn TR. The pharmacology of neuronal rescue with cerebral hypothermia. Early Hum Dev. 1998;53:19–35.
Northington FJ, Zelaya ME, O’Riordan DP, Blomgren K, Flock DL, Hagberg H, et al. Failure to complete apoptosis following neonatal hypoxia-ischemia manifests as “continuum” phenotype of cell death and occurs with multiple manifestations of mitochondrial dysfunction in rodent forebrain. Neuroscience. 2007;149:822–33.
Meier C, Middelanis J, Wasielewski B, Neuhoff S, Roth-Haerer A, Gantert M, et al. Spastic paresis after perinatal brain damage in rats is reduced by human cord blood mononuclear cells. Pediatr Res. 2006;59:244–9.
Pimentel-Coelho PM, Magalhaes ES, Lopes LM, deAzevedo LC, Santiago MF, Mendez-Otero R. Human cord blood transplantation in a neonatal rat model of hypoxic-ischemic brain damage: functional outcome related to neuroprotection in the striatum. Stem Cells Dev. 2010;19:351–8.
Yasuhara T, Hara K, Maki M, Xu L, Yu G, Ali MM, et al. Mannitol facilitates neurotrophic factor up-regulation and behavioural recovery in neonatal hypoxic-ischaemic rats with human umbilical cord blood grafts. J Cell Mol Med. 2010;14:914–21.
Geissler M, Dinse HR, Neuhoff S, Kreikemeier K, Meier C. Human umbilical cord blood cells restore brain damage induced changes in rat somatosensory cortex. PLoS One. 2011;6:e20194.
Rosenkranz K, Meier C. Umbilical cord blood cell transplantation after brain ischemia—from recovery of function to cellular mechanisms. Ann Anat. 2011;193:371–9.
Bennet L, Tan S, Van den Heuij L, Derrick M, Groenendaal F, van Bel F, et al. Cell therapy for neonatal hypoxia-ischemia and cerebral palsy. Ann Neurol. 2012;71:589–600.
http://www.haemotec.co.za/category/stem-cell-therapy/biosafe-sepax-automated-cell-processing/
Thompson CM, Puterman AS, Linley LL, Hann FM, van der Elst CW, Molteno CD, et al. The value of a scoring system for hypoxic ischaemic encephalopathy in predicting neurodevelopmental outcome. Acta Paediatr. 1997;86(7):757–61.
Acknowledgments
The authors thank Yasunori Ueda who is a director of Hematology of Kurashiki Central Hospital, and we also thank comedical staffs of Blood Transfusion and Cell Therapy Department of our hospital.
Conflict of Interest: The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Watabe, S., Sawada, M. (2018). Clinical Procedure of Cell Therapy: Separation and Infusion. In: Shintaku, H., Oka, A., Nabetani, M. (eds) Cell Therapy for Perinatal Brain Injury. Springer, Singapore. https://doi.org/10.1007/978-981-10-1412-3_11
Download citation
DOI: https://doi.org/10.1007/978-981-10-1412-3_11
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-1411-6
Online ISBN: 978-981-10-1412-3
eBook Packages: MedicineMedicine (R0)